Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer.
Moulder S, Gladish G, Ensor J, Gonzalez-Angulo AM, Cristofanilli M, Murray JL, Booser D, Giordano SH, Brewster A, Moore J, Rivera E, Hortobagyi GN, Tran HT. Moulder S, et al. Among authors: moore j. Cancer. 2012 May 1;118(9):2378-84. doi: 10.1002/cncr.26571. Epub 2011 Oct 17. Cancer. 2012. PMID: 22006179 Free PMC article. Clinical Trial.
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.
Morrow PK, Wulf GM, Ensor J, Booser DJ, Moore JA, Flores PR, Xiong Y, Zhang S, Krop IE, Winer EP, Kindelberger DW, Coviello J, Sahin AA, Nuñez R, Hortobagyi GN, Yu D, Esteva FJ. Morrow PK, et al. Among authors: moore ja. J Clin Oncol. 2011 Aug 10;29(23):3126-32. doi: 10.1200/JCO.2010.32.2321. Epub 2011 Jul 5. J Clin Oncol. 2011. PMID: 21730275 Free PMC article. Clinical Trial.
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.
Nelson BE, Saleem S, Damodaran S, Somaiah N, Piha-Paul S, Moore JA, Yilmaz B, Ogbonna D, Karp DD, Dumbrava E, Tsimberidou AM, Hong DS, Rodon Ahnert J, Milton DR, Zheng X, Booser DJ, Ibrahim NK, Conley AP, Bhosale P, Rojas Hernandez CM, Tripathy D, Naing A, Meric-Bernstam F. Nelson BE, et al. Among authors: moore ja. Cancer. 2023 Jul 15;129(14):2201-2213. doi: 10.1002/cncr.34773. Epub 2023 Apr 4. Cancer. 2023. PMID: 37016732 Free article. Clinical Trial.
A patient preference study comparing raltitrexed ('Tomudex') and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influence of side-effects and administration attributes.
Young A, Topham C, Moore J, Turner J, Wardle J, Downes M, Evans V, Kay S. Young A, et al. Among authors: moore j. Eur J Cancer Care (Engl). 1999 Sep;8(3):154-61. doi: 10.1046/j.1365-2354.1999.00152.x. Eur J Cancer Care (Engl). 1999. PMID: 10763646 Clinical Trial.
Development of SNP Panels from Low-Coverage Whole Genome Sequencing (lcWGS) to Support Indigenous Fisheries for Three Salmonid Species in Northern Canada.
Beemelmanns A, Bouchard R, Michaelides S, Normandeau E, Jeon HB, Chamlian B, Babin C, Hénault P, Perrot O, Harris LN, Zhu X, Fraser D, Bernatchez L, Moore JS. Beemelmanns A, et al. Among authors: moore js. Mol Ecol Resour. 2024 Nov 18:e14040. doi: 10.1111/1755-0998.14040. Online ahead of print. Mol Ecol Resour. 2024. PMID: 39552382
Patient Experiences of Using Wearable Health Monitors During Cancer Treatment: A Qualitative Study.
Collinson S, Ingram-Walpole S, Jackson C, Soliman A, Chan AKC, Tholouli E, Balata H, Merchant M, Kirkby KJ, Sweeney S, Blackhall F, Bashall T, Searle E, Pan S, Braun M, Kitchen GB, Moore JA, Merchant Z, Wilson AJ. Collinson S, et al. Among authors: moore ja. Clin Oncol (R Coll Radiol). 2024 Oct 20;37:103664. doi: 10.1016/j.clon.2024.10.036. Online ahead of print. Clin Oncol (R Coll Radiol). 2024. PMID: 39550935
12,298 results
You have reached the last available page of results. Please see the User Guide for more information.